E. Bratton

发表

Clinical Management and Outcomes of Patients in the Duke Cryptococcosis Clinical Cohort, 1996–2009

E. Bratton, 2012 .

Abstract 19090: Patient Characteristics and Lipid Lowering Treatment of Early Adopters of PCSK9i Therapies in the United States

P. Muntner, Tracy Y. Wang, H. Wirtz, 2017 .

Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation

M. Brookhart, K. Monda, P. Muntner, 2020, Journal of the American Heart Association.

Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non–Small Cell Lung Cancer (NSCLC)

R. Salgia, A. Amini, M. Villalona-Calero, 2022, American journal of clinical oncology.

Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant

J. Perfect, T. Stürmer, J. Juliano, 2012, PloS one.

Leveraging unstructured data to identify hereditary angioedema patients in electronic medical records

E. Brouwer, C. Mack, A. Near, 2021, Allergy, Asthma & Clinical Immunology.

Descriptive Study of Exposure to Inhalation Zanamivir and Pregnancy-Related Outcomes

R. Buus, E. Bratton, M. Thompson, 2014 .

Approaches to Antifungal Therapies and Their Effectiveness among Patients with Cryptococcosis

J. Perfect, T. Stürmer, J. Juliano, 2013, Antimicrobial Agents and Chemotherapy.

Prevalence of and risk for gastrointestinal bleeding and peptic ulcerative disorders in a cohort of HIV patients from a U.S. healthcare claims database

Monica G. Kobayashi, V. Vannappagari, E. Bratton, 2017, PloS one.

Correction: Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant

J. Perfect, T. Stürmer, J. Juliano, 2012, PLoS ONE.

Real world data for rare diseases research: The beginner’s guide to registries

J. Sultana, Ariel Arias, E. Bratton, 2023, Expert Opinion on Orphan Drugs.